Exercise for Type 1 Diabetes
(HOME T1D Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to study the effects of exercise on individuals with Type 1 Diabetes (T1D) and their muscle health. Researchers seek to understand how exercise training and breaks from exercise (de-training) impact men and women with T1D differently. The study will evaluate various exercise programs to determine which improves muscle and blood vessel health, enhancing insulin sensitivity and reducing blood sugar issues. The trial seeks adults with T1D who engage in less than 150 minutes of moderate-to-vigorous exercise weekly and are not on certain medications or have specific health conditions. As an unphased trial, this study offers a unique opportunity to contribute to understanding how exercise can improve health outcomes for people with T1D.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you use anti-inflammatory, glucocorticoid, or other pain-relief medications regularly.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that exercise is generally safe for people with Type 1 Diabetes (T1D). Studies indicate that aerobic exercise can improve heart and lung health, reduce insulin resistance, and improve blood fat levels. These benefits help prevent complications like heart disease.
Exercise also strengthens the immune system and enhances overall health for those with T1D. No strong evidence suggests serious negative effects when people with T1D exercise regularly. However, managing blood sugar levels carefully is important to avoid low blood sugar.
In summary, exercise is well-tolerated and beneficial for people with T1D. Following safe exercise guidelines and monitoring blood sugar levels is crucial.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the impact of structured exercise programs on managing Type 1 Diabetes, which traditionally relies on insulin therapy and dietary management. Unlike conventional treatments, this trial examines how different exercise regimens—ranging from a short detraining period to extended aerobic and resistance training—might influence blood sugar control, muscle strength, and overall health. By investigating these specific exercise protocols, researchers hope to uncover how physical activity can complement existing therapies, potentially leading to more holistic and personalized diabetes management strategies.
What evidence suggests that this trial's treatments could be effective for Type 1 Diabetes?
Research shows that exercise can greatly benefit people with Type 1 Diabetes (T1D). Activities like aerobic and resistance training make the body more responsive to insulin, enhancing its effectiveness. Exercise also increases the number of mitochondria, the energy producers in cells, leading to higher energy levels and better muscle function. Studies have found that exercise aids in weight loss and lowers the risk of heart disease. Additionally, physical activity can reduce the amount of insulin needed and improve overall fitness and health in adults with T1D. These benefits suggest that exercise is a promising way to manage T1D complications and enhance quality of life. This trial will explore these benefits further by comparing different exercise regimens, including a twelve-week exercise program and a four-week re-training program, against a one-week detraining period.16789
Who Is on the Research Team?
Thomas J Hawke, PhD
Principal Investigator
McMaster University
Are You a Good Fit for This Trial?
This trial is for adults aged 18-30 or 45-65 with Type 1 Diabetes who are not very active, doing less than the recommended amount of weekly exercise. It's not for those hospitalized multiple times for diabetic ketoacidosis, on certain medications, overweight (BMI >30), recent users of cannabis/tobacco/nicotine, or with other health issues that make exercising risky.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial physiological assessments to evaluate muscle health and establish baseline characteristics
Twelve-week Exercise
Participants undergo a combined aerobic and resistance training program
Detraining
Participants undergo a seven-day detraining period with unilateral knee immobilization
Four-week Re-training
Participants resume exercise program consisting of aerobic and resistance exercise
Follow-up
Participants are monitored for changes in muscle health and physiological parameters
What Are the Treatments Tested in This Trial?
Interventions
- De-training
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor